Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial assesses selinexor with radiation therapy for newly diagnosed diffuse intrinsic pontine glioma and high-grade glioma, in Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selinexor (selinexor)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Malignant Glioma | Phase 1, Phase 2 | Status: RECRUITING